The below information on Curosurf has been taken from official FDA sources, but we cannot guarantee it's accuracy. Please use this site for educational purposes only. This site does not replace a proper discussion with your doctor.

    Brand Name:Curosurf
    Generic:Poractant Alfa
This drug was approved by the FDA in one form or another on:
1999-11-18 ,
This drug is made in one form or another by the following companies:
Dey, LP
This drug is available in the following forms:
Intratracheal Suspensions
View the actual FDA approved label for this drug at the following links:

About Curosurf

Curosurf is used to treat or "rescue" premature babies with Respiratory Distress Syndrome (RDS). Curosurf reduces air trapped in the lining of the lungs (pneumothoraces) associated with RDS.

Curosurf is an extract of a natural substance (pig lung surfactant) necessary for effective breathing. Babies with RDS are lacking in this substance.

Precautions for Curosurf

Treatment with Curosurf is not a substitute for intensive care. Curosurf should only be given by health care professionals experienced in treating premature babies with RDS.

Side Effects of Curosurf

Curosurf is given to babies within several hours of birth by medical professionals in a hospital who will monitor the baby for any negative reactions.

Search the Web for more info:  

Recent Forum Posts on Curosurf

No active discussions on found. Why not post a question or comment yourself? Just click the link below.

Post a New Comment/Question on Curosurf in our forums.